Hepatitis E natural history: Difference between revisions
Joao Silva (talk | contribs) No edit summary |
Joao Silva (talk | contribs) No edit summary |
||
| Line 23: | Line 23: | ||
===Extra-Hepatic=== | ===Extra-Hepatic=== | ||
*Peripheral | *[[Peripheral neuropathy]] | ||
*Confusion | *[[Confusion]] | ||
*Ataxia | *[[Ataxia]] | ||
*[[Bell's palsy]] | |||
*Bell's palsy | *[[Guillain-Barré syndrome]] | ||
*[[Radiculopathy|Polyradiculopathy]] | |||
*Guillain-Barré syndrome | *[[Arthritis]] | ||
*[[Pancreatitis]] | |||
*Polyradiculopathy | *[[Aplastic anemia]] | ||
*Arthritis | |||
*Pancreatitis | |||
*Aplastic anemia | |||
==Prognosis== | ==Prognosis== | ||
Revision as of 20:46, 25 August 2014
|
Hepatitis E Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Hepatitis E natural history On the Web |
|
American Roentgen Ray Society Images of Hepatitis E natural history |
|
Risk calculators and risk factors for Hepatitis E natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Natural History
Hepatitis E may be classified in acute and chronic disease.[1]
Acute Hepatitis E
The clinical course of acute hepatitis E progresses according to the following phases:[2][3][4][5]
- Incubation period
- Lasts 3 to 8 weeks
- Prodromal phase
- Symptomatic period
- Lasts days to weeks
Chronic Hepatitis E
Complications
Extra-Hepatic
- Peripheral neuropathy
- Confusion
- Ataxia
- Bell's palsy
- Guillain-Barré syndrome
- Polyradiculopathy
- Arthritis
- Pancreatitis
- Aplastic anemia
Prognosis
In most immunocompetent patients, hepatitis E is self-limited. In these cases the prognosis is often good. Immunocompromised patients, and those with end-stage liver disease are at higher risk of developing chronic hepatitis and other complications. This last group of patients have a poor prognosis.[2]
References
- ↑ Hoofnagle JH, Nelson KE, Purcell RH (2012). "Hepatitis E." N Engl J Med. 367 (13): 1237–44. doi:10.1056/NEJMra1204512. PMID 23013075.
- ↑ 2.0 2.1 Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J; et al. (2012). "Hepatitis E." Lancet. 379 (9835): 2477–88. doi:10.1016/S0140-6736(11)61849-7. PMID 22549046.
- ↑ Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W; et al. (2008). "Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease". Eur J Gastroenterol Hepatol. 20 (8): 784–90. doi:10.1097/MEG.0b013e3282f5195a. PMID 18617784.
- ↑ Borgen K, Herremans T, Duizer E, Vennema H, Rutjes S, Bosman A; et al. (2008). "Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; a case series 2004 - 2006". BMC Infect Dis. 8: 61. doi:10.1186/1471-2334-8-61. PMC 2413240. PMID 18462508.
- ↑ Zhang S, Wang J, Yuan Q, Ge S, Zhang J, Xia N; et al. (2011). "Clinical characteristics and risk factors of sporadic Hepatitis E in central China". Virol J. 8: 152. doi:10.1186/1743-422X-8-152. PMC 3082222. PMID 21453549.